US Patent 7422739 Anti-CD20 antibodies
All edits
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+207 characters)
Article
Patent abstract
Disclosed are chimeric, immunologically active, isolated, and radiolabeled antibodies directed against the CD20 antigen. The antibodies are useful for treating and diagnosing B cell disorders.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07422739 Anti-CD20 antibodies US Patent 7422739 Anti-CD20 antibodies
Infobox
Patent Number
0742273900
Patent Number
742273900
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
074227390
Date of Patent
September 9, 2008
0Patent Application Number
099117030
Date Filed
July 25, 2001
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
074227390
Date of Patent
September 9, 2008
0Patent Application Number
099117030
Date Filed
July 25, 2001
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07422739 Anti-CD20 antibodies
Infobox
Is a
Patent jurisdiction
Patent number
07422739
Date of patent
September 9, 2008
Patent application number
09911703
Date Filed
July 25, 2001
Patent primary examiner
Find more entities like US Patent 7422739 Anti-CD20 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
